Details

Autor(en) / Beteiligte

• Chen, Xiuhui
• Mangala, Lingegowda S
• Mooberry, Linda
• Bayraktar, Emine
• Dasari, Santosh K
• Ma, Shaolin
• Ivan, Cristina
• Court, Karem A
• Rodriguez-Aguayo, Cristian
• Bayraktar, Recep
• Raut, Sangram
• Sabnis, Nirupama
• Kong, Xianchao
• Yang, Xianbin
• Lopez-Berestein, Gabriel
• Lacko, Andras G
• Sood, Anil K

Titel

Identifying and targeting angiogenesis-related microRNAs in ovarian cancer

Ist Teil von

• Oncogene, 2019-08, Vol.38 (33), p.6095-6108

Ort / Verlag

England: Nature Publishing Group

Erscheinungsjahr

2019

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Current anti-angiogenic therapy for cancer is based mainly on inhibition of the vascular endothelial growth factor pathway. However, due to the transient and only modest benefit from such therapy, additional approaches are needed. Deregulation of microRNAs (miRNAs) has been demonstrated to be involved in tumor angiogenesis and offers opportunities for a new therapeutic approach. However, effective miRNA-delivery systems are needed for such approaches to be successful. In this study, miRNA profiling of patient data sets, along with in vitro and in vivo experiments, revealed that miR-204-5p could promote angiogenesis in ovarian tumors through THBS1. By binding with scavenger receptor class B type 1 (SCARB1), reconstituted high-density lipoprotein-nanoparticles (rHDL-NPs) were effective in delivering miR-204-5p inhibitor (miR-204-5p-inh) to tumor sites to suppress tumor growth. These results offer a new understanding of miR-204-5p in regulating tumor angiogenesis.